Xuewei Xie

1.4k total citations
57 papers, 378 citations indexed

About

Xuewei Xie is a scholar working on Epidemiology, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xuewei Xie has authored 57 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Epidemiology, 30 papers in Cardiology and Cardiovascular Medicine and 15 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xuewei Xie's work include Acute Ischemic Stroke Management (33 papers), Antiplatelet Therapy and Cardiovascular Diseases (20 papers) and Cerebrovascular and Carotid Artery Diseases (15 papers). Xuewei Xie is often cited by papers focused on Acute Ischemic Stroke Management (33 papers), Antiplatelet Therapy and Cardiovascular Diseases (20 papers) and Cerebrovascular and Carotid Artery Diseases (15 papers). Xuewei Xie collaborates with scholars based in China, United States and United Kingdom. Xuewei Xie's co-authors include Yongjun Wang, Liping Liu, Yilong Wang, Hao Li, Xia Meng, Tan Xu, Jiang He, Jing Jing, Zhong Ju and Hongqiu Gu and has published in prestigious journals such as Annals of Internal Medicine, Neurology and Stroke.

In The Last Decade

Xuewei Xie

49 papers receiving 373 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuewei Xie China	10	166	135	76	74	54	57	378
Przemysław Puz Poland	10	155 0.9×	93 0.7×	68 0.9×	96 1.3×	46 0.9×	33	365
Zhengyi Li China	9	233 1.4×	168 1.2×	66 0.9×	99 1.3×	94 1.7×	16	477
Arata Abe Japan	12	176 1.1×	108 0.8×	76 1.0×	137 1.9×	106 2.0×	50	445
Maria Chondrogianni Greece	11	193 1.2×	75 0.6×	91 1.2×	68 0.9×	127 2.4×	52	409
Sebastian Luger Germany	13	151 0.9×	77 0.6×	127 1.7×	53 0.7×	110 2.0×	22	380
Smaranda Maier Romania	14	71 0.4×	96 0.7×	96 1.3×	69 0.9×	153 2.8×	71	507
Pol Camps‐Renom Spain	12	222 1.3×	119 0.9×	55 0.7×	140 1.9×	167 3.1×	44	433
Luís Prats‐Sánchez Spain	11	181 1.1×	83 0.6×	37 0.5×	90 1.2×	143 2.6×	27	313
Birgit Poltrum Austria	11	198 1.2×	55 0.4×	65 0.9×	78 1.1×	132 2.4×	12	414
Nicolas Martinez‐Majander Finland	11	205 1.2×	126 0.9×	39 0.5×	130 1.8×	68 1.3×	44	387

Countries citing papers authored by Xuewei Xie

Since Specialization

Citations

This map shows the geographic impact of Xuewei Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuewei Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuewei Xie more than expected).

Fields of papers citing papers by Xuewei Xie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuewei Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuewei Xie. The network helps show where Xuewei Xie may publish in the future.

Co-authorship network of co-authors of Xuewei Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Xuewei Xie. A scholar is included among the top collaborators of Xuewei Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuewei Xie. Xuewei Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhou, Yu, Xuewei Xie, Wanlin Zhu, et al.. (2025). Stroke-Aware CycleGAN: Improving Low-Field MRI Image Quality for Accurate Stroke Assessment. IEEE Transactions on Medical Imaging. 45(2). 693–703.

Wang, Mengxing, Aoming Jin, S. Claiborne Johnston, et al.. (2025). Effect of Stroke Severity on Efficacy and Safety of Indobufen versus Aspirin in Patients with Moderate to Severe Stroke: Results from the INSURE Randomized Clinical Trial. Journal of Atherosclerosis and Thrombosis. 32(12). 1586–1600.

Xie, Xuewei, Jing Jing, Anxin Wang, et al.. (2025). Dual antiplatelet therapy with ticagrelor vs clopidogrel in patients with TIA or minor stroke with or without symptomatic carotid artery stenosis: a post hoc analysis of the CHANCE-2 trial. Stroke and Vascular Neurology. 10(5). 551–559. 1 indexed citations

Jing, Jing, Anxin Wang, Xuewei Xie, et al.. (2024). Efficacy and safety of dual antiplatelet therapy in the elderly for stroke prevention: a subgroup analysis of the CHANCE-2 trial. Stroke and Vascular Neurology. 9(5). 541–550. 3 indexed citations

Meng, Xia, Anxin Wang, Xue Tian, et al.. (2024). One-Year Outcomes of Early Therapy With Ticagrelor vs Clopidogrel in CYP2C19 Loss-of-Function Carriers With Stroke or TIA Trial. Neurology. 102(3). e207809–e207809. 2 indexed citations

Xie, Xuewei, Jing Jing, Xia Meng, et al.. (2024). Dual Antiplatelet Therapy After Embolic Stroke of Undetermined Source: A Subgroup Analysis of the CHANCE-2 Trial. Stroke. 55(7). 1739–1747.

Jing, Jing, Xia Meng, Anxin Wang, et al.. (2023). Ticagrelor Versus Clopidogrel in Minor Stroke or Transient Ischemic Attack With Intracranial Artery Stenosis: A Post Hoc Analysis of CHANCE‐2. Journal of the American Heart Association. 12(21). e031611–e031611. 7 indexed citations

Xie, Xuewei, S. Claiborne Johnston, Anxin Wang, et al.. (2023). Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin. JAMA Network Open. 6(6). e2317037–e2317037. 3 indexed citations

Wang, Anxin, Xuewei Xie, Xue Tian, et al.. (2022). Ticagrelor–Aspirin Versus Clopidogrel–Aspirin Among CYP2C19 Loss-of-Function Carriers With Minor Stroke or Transient Ischemic Attack in Relation to Renal Function: A Post Hoc Analysis of the CHANCE-2 Trial. Annals of Internal Medicine. 175(11). 1534–1542. 5 indexed citations

10.

Wang, Anxin, Xia Meng, Xue Tian, et al.. (2022). Effect of Hypertension on Efficacy and Safety of Ticagrelor-Aspirin Versus Clopidogrel-Aspirin in Minor Stroke or Transient Ischemic Attack. Stroke. 53(9). 2799–2808. 4 indexed citations

11.

Jing, Jing, Xuewei Xie, S. Claiborne Johnston, et al.. (2022). Genotype‐Guided Dual Antiplatelet Use for Transient Ischemic Attack and Minor Stroke by Imaging Status: Subgroup Analysis of the CHANCE‐2 Trial. Annals of Neurology. 93(4). 783–792. 4 indexed citations

12.

Chen, Pan, Qiong Wu, Xuewei Xie, et al.. (2022). Systolic blood pressure and recurrent stroke in patients with different lesion patterns on diffusion weighted imaging. Journal of Clinical Hypertension. 24(10). 1350–1357. 1 indexed citations

13.

Liu, Liping, Yilong Wang, Yilong Wang, et al.. (2021). China Antihypertensive Trial in Acute Ischemic Stroke II (CATIS-2): rationale and design. Stroke and Vascular Neurology. 6(2). 286–290. 4 indexed citations

14.

Zheng, Xiaowei, Yanbo Peng, Chongke Zhong, et al.. (2021). Systolic Blood Pressure Trajectories After Discharge and Long-Term Clinical Outcomes of Ischemic Stroke. Hypertension. 77(5). 1694–1702. 7 indexed citations

15.

Zhu, Zhengbao, Mengyao Shi, Aili Wang, et al.. (2021). Association between annual household income and adverse outcomes in patients who had ischaemic stroke. Journal of Epidemiology & Community Health. 76(3). 293–300. 7 indexed citations

16.

Wang, Yongjun, Yongjun Wang, Claiborne Johnston, et al.. (2021). Clopidogrel with aspirin in High-risk patients with Acute Non-disabling Cerebrovascular Events II (CHANCE-2): rationale and design of a multicentre randomised trial. Stroke and Vascular Neurology. 6(2). 280–285. 33 indexed citations

17.

Xie, Xuewei, Daniel T. Laskowitz, Xingquan Zhao, et al.. (2019). Effect of dual versus mono antiplatelet therapy on recurrent stroke modulated by activated partial thromboplastin time. European Journal of Neurology. 26(9). 1168–1168. 5 indexed citations

18.

Xie, Xuewei, Hongqiu Gu, Xianwei Wang, et al.. (2019). Assessing the applicability of 2017 ACC/AHA hypertension guidelines for secondary stroke prevention in the BOSS study. Journal of Clinical Hypertension. 21(10). 1534–1541. 2 indexed citations

19.

Xu, Jie, Bo Song, Xuewei Xie, et al.. (2017). Short-term blood pressure variability and long-term blood pressure variability: which one is a reliable predictor for recurrent stroke. Journal of Human Hypertension. 31(9). 568–573. 15 indexed citations

20.

Tang, Zhouping, Na Liu, Zaiwang Li, et al.. (2010). In vitro evaluation of the compatibility of a novel collagen-heparan sulfate biological scaffold with olfactory ensheathing cells.. PubMed. 123(10). 1299–304. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact